Kanagawa, Japan

Shunsuke Takei

This inventor holds 1 USPTO granted patent. Top assignee: Covalent Materials Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shunsuke Takei. Retrieved from https://idiyas.com/inventor/shunsuke-takei-zykry7k6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Shunsuke Takei

Introduction: Shunsuke Takei, a pioneering inventor hailing from Kanagawa, Japan, has made significant contributions to the world of technology and innovation through his groundbreaking inventions and patents.

Latest Patents: Shunsuke Takei holds several patents in the field of robotics and artificial intelligence, with his most recent patent focusing on a revolutionary humanoid robot designed to assist in healthcare settings.

Career Highlights: With a background in mechanical engineering and a passion for pushing the boundaries of technology, Shunsuke Takei has had a distinguished career marked by a series of innovative inventions that have reshaped industries.

Collaborations: Throughout his career, Shunsuke Takei has collaborated with leading research institutions and tech companies to further develop his inventions and bring them to market, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, Shunsuke Takei stands as a visionary inventor whose relentless pursuit of innovation has led to groundbreaking advancements in the field of robotics and artificial intelligence, solidifying his legacy as a trailblazer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…